Aspira Pathlab & Diagnostics Ltd is in the business of pathology and related healthcare servicesBusiness Overview: Company is in the business of running, owning, managing and administering Diagnostics Centers in Mumbai
Aspira Pathlab's board has approved the financial results for the first quarter ended June 30, 2025. Standalone revenue from operations was ₹5.25 Cr, with a profit after tax of ₹0.07 Cr. On a consolidated basis, revenue from operations was ₹5.25 Cr, reporting a profit after tax of ₹0.42 Cr. The...
Aspira Pathlab & Diagnostics Limited has announced a board meeting to approve the re-appointment and remuneration of Dr. Pankaj Shah as Managing Director & CEO for a three-year term from August 2025 to July 2028. Dr. Shah brings over 43 years of pathology experience and has been a key figure...
Aspira Pathlab & Diagnostics Limited has announced a compliance certificate from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited, confirming the successful processing of securities received for dematerialisation during the recent quarter. This includes acceptance or rejection of demat requests, cancellation of physical certificates after verification, and...
Aspira Pathlab & Diagnostics Limited has announced the inauguration of three new diagnostic centres in Gujarat—two in Surat and one in Navsari. These centres are expected to generate combined revenue of approximately INR 10.7 crore over the next three years, enhancing the company’s presence and service capacity in the region....
Aspira Pathlab & Diagnostics Limited has announced a board meeting on the acquisition of 100% stake in its associate Aspira DNA Diagnostics Gujarat LLP, followed by striking off the LLP. The company executed a Business Transfer Agreement to acquire all assets and liabilities of the LLP in a related party...
